Aprea Therapeutics (APRE) Assets (2018 - 2026)
Aprea Therapeutics' Assets came in at $42.29 million for Q2 2026, up 144.3% from $17.31 million a year earlier but down 11.2% from the prior quarter.
Powered by 
Analysis
Aprea Therapeutics (APRE) Assets (2018 - 2026) Analysis & Trends
At the end of FY2025, Aprea Therapeutics' Assets was $15.93 million, down 33.6% from FY2024.
- Assets carries a five-year compound annual growth rate of -29.7% (FY2020 to FY2025).
- Going back by year, Assets was $23.98 million in FY2024 (+5.9%), $22.65 million in FY2023 (-24.9%), $30.16 million in FY2022 (-46.9%) and $56.82 million in FY2021 (-38.8%).
- The five-year range for quarterly Assets is $14.32 million (Q3 2025) to $62.48 million (Q3 2021).
- Year-over-year, Assets increased in four of the last eight quarters, with growth averaging 16.0%.
- The fastest year-over-year change in Assets over five years came in Q2 2026 (growth of 144.3%), and the weakest in Q4 2022 (a decline of 46.9%).
- Business Quant data shows APRE's Assets at $47.61 million (Q1 2026), $15.93 million (Q4 2025) and $14.32 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Aprea Therapeutics | 40.11 Mn | 40.11 Mn | - | 42.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.29 Mn |
| Mar 31, 2026 | 47.61 Mn |
| Dec 31, 2025 | 15.93 Mn |
| Sep 30, 2025 | 14.32 Mn |
| Jun 30, 2025 | 17.31 Mn |
| Mar 31, 2025 | 20.22 Mn |
| Dec 31, 2024 | 23.98 Mn |
| Sep 30, 2024 | 26.89 Mn |
| Jun 30, 2024 | 29.96 Mn |
| Mar 31, 2024 | 33.20 Mn |
| Dec 31, 2023 | 22.65 Mn |
| Sep 30, 2023 | 25.77 Mn |
| Jun 30, 2023 | 28.68 Mn |
| Mar 31, 2023 | 32.02 Mn |
| Dec 31, 2022 | 30.16 Mn |
| Sep 30, 2022 | 33.62 Mn |
| Jun 30, 2022 | 40.68 Mn |
| Mar 31, 2022 | 50.34 Mn |
| Dec 31, 2021 | 56.82 Mn |
| Sep 30, 2021 | 62.48 Mn |
API Access
Aprea Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=APRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "APRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=APRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();